News

Technology News

Approach Developed For Treating Angelman Syndrome

Friday, December 23, 2011 5:01:00 AM PDT | VentureDeal Staff
Chapel Hill, North Carolina  --  A team of scientists and doctors at the University of North Carolina at Chapel Hill has announced the discovery of a potential treatment for Angelman Syndrome.

The syndrome, which is a neuro-genetic disorder similar to autism, occurs in approximately 1 in 15,000 live births and results in severe neurological impairment for the lifetime of the child.

Silence of the Ube3a gene was determined to be the cause of the syndrome, and for the first time a drug compound has been used to restore proper function of the gene.

The team said that conducting pre-clinical trials will be the next step in evaluation.

Email Page  Email Page | Print Page Print Page

Free Trial

Want unlimited access to the complete database with thousands of technology companies, VCs and transactions for only $25 per month?

Start your Free 14 Day Trial now – no obligation or credit card required.

Free 14 day trial. No Obligation. Click to Register.
Venturedeal Twitter Venturedeal Facebook Venturedeal Linkedin


PCI - Level1